Cirrhosis Risk Prediction in individuals with Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease

被引:0
|
作者
Chun, Ji Sun [1 ,2 ]
Song, Yuri [1 ,2 ]
Lee, Woo Vin [1 ,2 ]
Ko, Minoh [1 ,2 ]
Jang, Ha Young [3 ]
Kim, In-Wha [1 ,2 ]
Kim, Hyunah [4 ]
Song, Yun-Kyoung [5 ]
Park, Sehoon [6 ]
Lee, Hajeong [6 ]
Lee, Hae-Young [6 ]
Kwak, Soo Heon [6 ]
Oh, Jung Mi [1 ,2 ]
机构
[1] Seoul Natl Univ, Coll Pharm, Seoul, South Korea
[2] Seoul Natl Univ, Pharmaceut Sci Res Inst, Seoul, South Korea
[3] Gachon Univ, Coll Pharm, Incheon, South Korea
[4] Sookmyung Womens Univ, Coll Pharm, Seoul, South Korea
[5] Catholic Univ Korea, Seoul, South Korea
[6] Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea
关键词
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
1241
引用
收藏
页码:559 / 559
页数:1
相关论文
共 50 条
  • [31] Protective effect of celastrol on type 2 diabetes mellitus with nonalcoholic fatty liver disease in mice
    Sun, JuanJuan
    Wang, Hui-juan
    Yu, Jun
    Li, TingTing
    Han, YiDi
    FOOD SCIENCE & NUTRITION, 2020, 8 (11): : 6207 - 6216
  • [32] The aggravation of mitochondrial dysfunction in nonalcoholic fatty liver disease accompanied with type 2 diabetes mellitus
    Liu, Xiaolin
    Zhang, Jingyi
    Ming, Yanan
    Chen, Xiaoyu
    Zeng, Minde
    Mao, Yimin
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2015, 50 (09) : 1152 - 1159
  • [33] Sociodemographic and genetic determinants of nonalcoholic fatty liver disease in type 2 diabetes mellitus patients
    Muhammad Adnan
    Abdul Wajid
    Wasif Noor
    Andleeb Batool
    Muhammad Aasim
    Kamran Abbas
    Quratul Ain
    Journal of Genetic Engineering and Biotechnology, 20
  • [34] Interrelation of Nonalcoholic Fatty Liver Disease and Hemodynamic Values in Type 2 Diabetes Mellitus Patients
    Chernyaeva, Anna
    Kravchun, Nonna
    Zemlyanitsyna, Olga
    Chernyavskaya, Iryna
    Dorosh, Helen
    Romanova, Iryna
    Polozova, Lubov
    Dunayeva, Inna
    Karachentsev, Iurii
    DIABETES, 2016, 65 : A121 - A121
  • [35] Sociodemographic and genetic determinants of nonalcoholic fatty liver disease in type 2 diabetes mellitus patients
    Adnan, Muhammad
    Wajid, Abdul
    Noor, Wasif
    Batool, Andleeb
    Aasim, Muhammad
    Abbas, Kamran
    Ain, Quratul
    JOURNAL OF GENETIC ENGINEERING AND BIOTECHNOLOGY, 2022, 20 (01)
  • [36] Role of Canagliflozin in the Evolution of Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus
    Tejera-Perez, Cristina
    Sanchez-Bao, Ana
    Soto-Gonzalez, Alfonso
    Bellido-Guerrero, Diego
    DIABETES, 2017, 66 : A346 - A346
  • [37] Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus in Post-menopausal women
    Sud, S.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2023, 197
  • [38] Efficacy and Safety of Sitagliptin for the Treatment of Nonalcoholic Fatty Liver Disease with Type 2 Diabetes Mellitus
    Fukuhara, Takayuki
    Hyogo, Hideyuki
    Ochi, Hidenori
    Fujino, Hatsue
    Kan, Hiromi
    Naeshiro, Noriaki
    Honda, Yohji
    Miyaki, Daisuke
    Kawaoka, Tomokazu
    Tsuge, Masataka
    Hiramatsu, Akira
    Imamura, Michio
    Kawakami, Yoshiiku
    Aikata, Hiroshi
    Chayama, Kazuaki
    HEPATO-GASTROENTEROLOGY, 2014, 61 (130) : 323 - 328
  • [39] Transient remission of nonalcoholic fatty liver disease decreases the risk of incident type 2 diabetes mellitus in Japanese men
    Fukuda, Takuya
    Hamaguchi, Masahide
    Kojima, Takao
    Mitsuhashi, Kazuteru
    Hashimoto, Yoshitaka
    Ohbora, Akihiro
    Kato, Takahiro
    Nakamura, Naoto
    Fukui, Michiaki
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2016, 28 (12) : 1443 - 1449
  • [40] Nonalcoholic fatty liver disease is associated with an increased risk of heart block in hospitalized patients with type 2 diabetes mellitus
    Mantovani, Alessandro
    Rigolon, Riccardo
    Pichiri, Isabella
    Bonapace, Stefano
    Morani, Giovanni
    Zoppini, Giacomo
    Bonora, Enzo
    Targher, Giovanni
    PLOS ONE, 2017, 12 (10):